Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.58 |
| ▸ | THRB | P10828 | 2/20 | 0.48 |
| ▸ | THRA | P10827 | 1/20 | 0.48 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.47 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.47 |
| ▸ | BID | P55957 | 3/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.45 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.45 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.45 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.45 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 1/20 | 0.45 |
| ▸ | EP300 | Q09472 | 1/20 | 0.45 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.45 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.45 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.45 |
| ▸ | CYSLTR2 | Q9NS75 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2970921 | 1.00 | LIPG (0.58) | LIPGTHRBTHRANR1H2NR1H3 | |
| SCHEMBL9859793 | 1.00 | LIPG (0.58) | LIPGTHRBTHRANR1H2NR1H3 | |
| SCHEMBL27261574 | 1.00 | LIPG (0.58) | LIPGTHRBTHRANR1H2NR1H3 | |
| SCHEMBL10716860 | 1.00 | LIPG (0.58) | LIPGTHRBTHRANR1H2NR1H3 | |
| SCHEMBL6679819 | 1.00 | LIPG (0.58) | LIPGTHRBTHRANR1H2NR1H3 | |
| SCHEMBL5171915 | 1.00 | LIPG (0.58) | LIPGTHRBTHRANR1H2NR1H3 | |
| SCHEMBL28410253 | 1.00 | LIPG (0.58) | LIPGTHRBTHRANR1H2NR1H3 | |
| SCHEMBL9479874 | 1.00 | LIPG (0.58) | LIPGTHRBTHRANR1H2NR1H3 | |
| SCHEMBL20594223 | 1.00 | LIPG (0.58) | LIPGTHRBTHRANR1H2NR1H3 | |
| SCHEMBL617128 | 0.98 | LIPG (0.55) | LIPGTHRBTHRANR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 282 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1595936-B1 | COMPOSITION FOR EXTERNAL USE | VITAMIN C60 BIORES CORP (JP) | 2011-10-19 | — | — | EP | claimed |
| US-20060134095-A1 | Antioxidative composition and composition for external use | VITAMIN C60 BIORESEARCH CORPORATION (JP) | 2006-06-22 | — | — | US | claimed |
| EP-1595936-A1 | ANTIOXIDATIVE COMPOSITION AND COMPOSITION FOR EXTERNAL USE | MITSUBISHI CORPORATION (JP) | 2005-11-16 | — | — | EP | claimed |
| EP-4682106-A1 | FATTY ACID-TREATED ZINC OXIDE PARTICLES, METHOD FOR PRODUCING SAME, AND DISPERSION AND COSMETIC HAVING SAME BLENDED THEREIN | Sakai Chemical Industry Co., Ltd. (JP) | 2026-01-21 | — | — | EP | disclosed |
| EP-4620453-A1 | AQUEOUS DISPERSION OF SURFACE-HYDROPHOBIZED INORGANIC POWDER AND COSMETIC PREPARATION CONTAINING SAME | Nikko Chemicals Co., Ltd. (JP) | 2025-09-24 | — | — | EP | disclosed |
| WO-2025105415-A1 | MELANOGENESIS INHIBITOR AND EXTERNAL PREPARATION FOR SKIN CONTAINING SAME | 三菱瓦斯化学株式会社 | 2025-05-22 | — | — | WO | disclosed |
| CN-119497608-A | Composition and method for producing the same | 株式会社资生堂 | 2025-02-21 | — | — | CN | disclosed |
| US-20250034401-A1 | ZINC OXIDE PARTICLES EACH HAVING SURFACE COATED WITH ORGANOSILICON, METHOD FOR PRODUCING SAME, COSMETIC PREPARATION, DISPERSION, HEAT DISSIPATING FILLER AND RESIN COMPOSITION | SAKAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2025-01-30 | — | — | US | disclosed |
| US-12109294-B2 | Oily moisturizer and topical skin composition containing same | THE NISSHIN OILLIO GROUP, LTD. (JP) | 2024-10-08 | — | — | US | disclosed |
| WO-2024204123-A1 | FATTY ACID-TREATED ZINC OXIDE PARTICLES, METHOD FOR PRODUCING SAME, AND DISPERSION AND COSMETIC HAVING SAME BLENDED THEREIN | 堺化学工業株式会社 | 2024-10-03 | — | — | WO | disclosed |
| EP-4424641-A1 | ZINC OXIDE PARTICLES EACH HAVING SURFACE COATED WITH ORGANOSILICON, METHOD FOR PRODUCING SAME, COSMETIC PREPARATION, DISPERSION, HEAT DISSIPATING FILLER AND RESIN COMPOSITION | Sakai Chemical Industry Co., Ltd. (JP) | 2024-09-04 | — | — | EP | disclosed |
| EP-0225602-B1 | ALPHA-HYDROXYTHIO ETHERS | CIBA-GEIGY AG (CH) | 1991-10-09 | — | — | EP | disclosed |
| EP-0228045-B1 | AROMATIC THIOETHERS | CIBA-GEIGY AG (CH) | 1991-04-03 | — | — | EP | disclosed |
| US-4919846-A | Conditioning low skin sensitivity | SHISEIDO COMPANY LTD. (JP) | 1990-04-24 | — | — | US | disclosed |
| EP-0348091-A1 | Aerosol composition | SHISEIDO COMPANY LIMITED (JP) | 1989-12-27 | — | — | EP | disclosed |
| US-4808572-A | ANTIALLERGENS | CIBA-GEIGY CORPORATION (US) | 1989-02-28 | — | — | US | disclosed |
| EP-0303713-A1 | PERCUTANEOUS ABSORPTION PROMOTER AND DERMATOLOGIC PREPARATION FOR EXTERNAL USE | SHISEIDO COMPANY LIMITED (JP) | 1989-02-22 | — | — | EP | disclosed |
| US-4785004-A | ANTIALLERGENS, ANTIHISTAMINES | CIBA-GEIGY CORPORATION (US) | 1988-11-15 | — | — | US | disclosed |
| EP-0228045-A2 | Aromatic thioethers | CIBA-GEIGY AG (CH) | 1987-07-08 | — | — | EP | disclosed |
| EP-0225602-A2 | Alpha-hydroxythio ethers | CIBA-GEIGY AG (CH) | 1987-06-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060134095-A1 | Antioxidative composition and composition for external use | GPX4, GPX1, SOD1 | LIPG 725/4885THRB 4553/4885THRA 4159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.